iTeos Therapeutics Inc.

NASDAQ: ITOS · Real-Time Price · USD
10.11
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
10.11
0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT

iTeos Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
35M 12.6M 267.63M 344.77M
Cost of Revenue
1.24M 898K 813K 615K
Gross Profit
33.76M 11.7M 266.82M 344.16M
Operating Income
-159.53M -151.1M 126.32M 244.9M
Interest Income
30.87M 31.77M 11.36M 78K
Pretax Income
-120.34M -109.03M 147.56M 256.46M
Net Income
-134.41M -112.64M 96.65M 214.52M
Selling & General & Admin
49.08M 50.4M 43.95M 40.51M
Research & Development
145.45M 113.3M 97.36M 59.37M
Other Expenses
-1.24M -898K -813K -615K
Operating Expenses
193.29M 162.8M 140.49M 99.26M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
194.53M 163.7M 141.31M 99.87M
Income Tax Expense
14.07M 3.61M 52.08M 41.94M
Shares Outstanding (Basic)
40.47M 35.76M 35.55M 35.18M
Shares Outstanding (Diluted)
40.47M 35.76M 37.77M 37.77M
EPS (Basic)
-3.32 -3.15 2.72 6.10
EPS (Diluted)
-3.32 -3.15 2.56 5.68
EBITDA
-121.82M -111.66M 148.38M 257.08M
EBIT
-123.06M -112.56M 147.56M 256.46M
Depreciation & Amortization
1.24M 898K 813K 615K